PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 181 of 623

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

PR NewswireOriginal source
🌍Regulatoryifpma.orgTier 1 · Regulatory source

76th WHO Regional Committee for Africa: Strategy for financing the future of health in the WHO African Region, 2026–2035

IFPMA GlobalOriginal source
🇯🇵Researchkyoto-u.ac.jpTier 2 · Direct publisher

Looking into the eyes of gibbons

Kyoto UniversityOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Med-Rx Medication/Primary Solution Administration Kit

CHS was notified by ICU Medical Canada that they are conducting a recall of certain IV sets as disco...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Maquet Percutaneous Insertion Kit and Dilator Sets

The manufacturer became aware of this issue during retrospective review of historical packaging veri...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Cyanosure DermaV Laser System

Cynosure Lutronic has identified a adverse trend of complaint reports in North America for spark and...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

CARESCAPE Central Station

GE Healthcare has become aware that the CARESCAPE Central Station (CSCS) v3.0.x may not resume patie...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

BIOFIRE® Joint Infection Panel – 30 Pack

Beginning April 5, 2026, elevated rates of KPC unexpected positives were observed in reagent final Q...

Health Canada Recalls and Safety AlertsOriginal source
🌍Devicesnews.henryschein.comTier 3 · Secondary coverage

BioHorizons releases Prolifica™ allogeneic growth factor technology for advanced promotion of bone healing & regeneration

Henry ScheinOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sichuan Biokin Pharmaceutical Co: Net loss deepened on surging R&D, but global first-in-class drug approvals marked a milestone

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Says Vitruvias Recalls One Lot of 30 mg Thyroid Tablets

iNews ZoombanglaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How biotech is treating epilepsy beyond seizures

European Biotechnology MagazineOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

FDA Drug Safety CommunicationsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Massachusetts Biotech Jobs Plunge for First Time in Over Two Decades

New Bedford GuideOriginal source
🇩🇪Researchuni-freiburg.deTier 2 · Direct publisher

Startup Project: Through the Gate to the Heart

University of FreiburgOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Could the U.S. Ban Chinese Medical Data?

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe

PharmTech.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Akeso, Summit hail ivonescimab’s biliary tract cancer win in China-only Phase 3 trial

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

TradingViewOriginal source
🌍Regulatoryinfarma.plTier 1 · Regulatory source

Polityka lekowa powinna optymalizować efekt zdrowotny, nie tylko budżet

INFARMA PolandOriginal source
🇺🇸Industryinvestor.lilly.comTier 1 · Company source

Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study

Eli Lilly NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun Pharmaceutical : Net profit grew 12.7% to ¥1.13 billion despite a 2.7% revenue decline, aided by one-time gains

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Metsera backers establish new biotech armed with China-licensed immunology asset

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

ESC 2026: Common pharma excipient linked to uptick in cardiovascular risk

Pharmaceutical TechnologyOriginal source
🇺🇸Industrythefdalawblog.comTier 3 · Secondary coverage

Top Ten Essentials for Preventing Hospital Controlled Substance Diversion

Hyman, Phelps & McNamara (FDA Law)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Delivers First Gene Therapy FDA Approval for GSDIa

Streetwise ReportsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Seven drug regulators, including the EU, UK, and Canada, have warned since 2019 that antidepressant-linked sexual side effects can persist for years after the drug is stopped. The US hasn't.

ScienceBlog.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Inna Gruber Appointed Senior Director, Global Business Development at Lotus Pharmaceutical

hrtoday.inOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (WST) Looks 14% Undervalued, Is The Premium Valuation Still Justified?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Qlife receives first revenue from pharmaceutical deal

BiostockOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Biotech Growth Trust PLC – LSE:BIOG

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vivace Therapeutics names new CEO as it prepares Phase 3 trial for mesothelioma drug

Proactive financial newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical CDMO Market Size, Report 2026-2035

Global Market Insights Inc.Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Hansoh Pharmaceutical Group: Net profit surged 35.8% on double-digit revenue growth and strong innovative medicine sales

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lady Gaga reveals role at biotech Outer Bio

BioXconomyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves drug to treat HIV infection in newborns

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

AOL.caOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical files for Phase 3 trial in Korea of biweekly obesity drug candidate ‘bofanglutide’

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

HLB Therapeutics completes global Phase 3 trial of NK eye drop candidate ‘RGN-259,’ with topline results expected in November

더바이오Original source
🌍discoverynews.google.comTier 2 · Trade media

SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch

Fierce BiotechOriginal source
🇧🇪Regulatoryfamhp.beTier 1 · Regulatory source

Actualisering van de lijst van essentiële stoffen voor voedselproducerende paarden

FAMHP BelgiumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - GENB +15%, BDSX +10%, CDNA +6%, CPIX +10%, CRDL +7%

RTTNewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BlackRock Inc. Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Analysis of the health of Sellafield workers in the National Registry for Radiation Workers (NRRW)

The main aim of the NRRW is to evaluate the impact of radiation exposure on the risks from both canc...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

NRRW study information: guidance, privacy notice, governance group and publications

The National Registry for Radiation Workers (NRRW) is a long-term follow-up study of the health of r...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Guidance on expedited syphilis testing and treatment for inclusion health groups

Guidance for healthcare professionals working in settings and contexts where traditional healthcare...

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Giardia: national laboratory data

Annual data of reported Giardia infections in England since 2007.

UK Health Security AgencyOriginal source
🇨🇭Industryinterpharma.chTier 1 · Company source

Die Schweiz verliert als klinischer Forschungsstandort zunehmend an Bedeutung

Interpharma SwitzerlandOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Australia Pharmaceutical Grade Sodium Carbonate - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SK Biopharmaceuticals invests 1.1t won, targets US with next-gen epilepsy drug - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Caliway’s CBL-514 Phase 2 Combination Trial Cleared; Phase 3 SUPREME-01 Enrolling

The Clinical Trial VanguardOriginal source
🌍Industrymonashhealth.orgTier 1 · Company source

Referring patients with suspected cardiac emergencies to the VHH

Monash HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Algert Global LLC Reduces Position in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approval for Slimming Teas Weight Loss: What It Really Means and How to Use It Safely *bh4jSeiMO*

Villa de la OrotavaOriginal source